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Abstract 
Background and Aims 
There are few data on the prevalence of synchronous colorectal lesions in patients who have 
large lateral spreading tumors.  We sought to describe the rate of synchronous lesions found in 
patients who underwent endoscopic resection of large sessile adenomas and serrated lesions. 
 
Methods 
This is a retrospective assessment of a prospectively created database of 728 consecutive patients 
with large lateral spreading tumors (LLST) resected who underwent complete clearing of the 
colon during two colonoscopies by a single expert endoscopist. 
 
Results 
The 728 patients with resected LLSTs and complete clearing had 4578 synchronous lesions, 
including 584 patients (802%) with at least one synchronous conventional adenoma, 132 (18.1%) 
with at least one synchronous conventional adenoma ≥ 20 mm in size, 294 (40.4%) with at least 
one synchronous advanced conventional adenoma, and 6 patients with a synchronous lesion with 
cancer. Patients with an index large sessile conventional adenoma compared to those with an 
index large serrated lesion had on average more synchronous conventional adenomas (4.8 vs 2.9, 
p=0.001) and fewer synchronous serrated lesions (1.4 vs 4.5, p<0.001). Of the 97 patients with a 
serrated class index lesion, 28 (28.9%) met criteria for serrated polyposis. 
 
Conclusions 
There is a very high prevalence of synchronous lesions, including other large and advanced 
synchronous lesions, in patients with flat or sessile conventional adenomas and serrated 
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colorectal polyps.  Patients with large lateral spreading tumors in the colon need detailed clearing 
of the rest of the colon. Patients referred for endoscopic resection of serrated lesions ≥ 20 mm 
have a very high prevalence of serrated polyposis. This study has potential implications for 
further stratification of high risk patient groups in post-polypectomy surveillance guidelines. 
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Introduction 
Guidelines emphasize high quality colonoscopy examinations to decrease the risk of interval 
cancer.1 Large colon polyps are associated with an increased risk of developing metachronous 
advanced neoplasia at the interval exam.2 However, this may be attributable to missed 
synchronous lesions as opposed to early metachronous lesions. Prior studies demonstrated an 
increased risk of synchronous advanced adenomas in patients with large flat polyps3, large 
sessile adenomas4 and large serrated polyps5-11. 
 
The aim of this study is to systematically describe synchronous lesions found in patients who 
underwent endoscopic resection of large (≥ 20 mm in size) lateral spreading tumors.  To our 
knowledge, this is the largest study to address this issue. 
 
Methods 
This is a retrospective evaluation of a prospectively created database of large (≥ 20 mm in size) 
lateral spreading tumors (LLST) referred to and resected by a single endoscopist (DKR) between 
April 2000 and December 2015. Review of the database was approved by the Institutional 
Review Board at Indiana University Health Partners on June 16, 2015. 
 
In many cases DKR removed the LLST during the baseline colonoscopy but did not clear the 
entire colon until the first follow-up colonoscopy. Patients were encouraged to return to our 
center within 3-6 months for surveillance of the polypectomy site with clearance of the 
remaining colon, but some patients underwent follow-up colonoscopy by the referring physician 
because of travel distance. Patients were included if they had at least 2 colonoscopies performed 
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by DKR within 1 year. Patients were excluded if they had known familial adenomatous 
polyposis, if the index large polyp was pedunculated, < 2 cm in maximum diameter, or if it was 
not an adenoma, serrated lesion, or cancer (e.g. inflammatory polyp). Synchronous inflammatory 
polyps and other non-adenomatous/non-serrated class lesions are not reported here. 
 
The database contains patient demographics, polyp information, and histopathologic data. The 
largest lesion in a patient was considered the index LLST. Polyps were considered synchronous 
if they were identified during the baseline procedure or any subsequent procedure within 12 
months. There were 658 cases in which the LLST was referred by another colonoscopist and 70 
cases in which the study endoscopist detected the index LLST during a screening, surveillance, 
or diagnostic colonoscopy. The colonoscopy and pathology reports from the referring physician 
and institution were available in all cases at the time of the initial LLST resection at our center 
but were entered into our database in only 328 of the 658 cases. To try and capture the full 
degree of synchronous lesions, synchronous polyps resected by the referring endoscopist were 
included if the procedure and pathology reports were available in our database. 
 
Conventional adenomas included tubular adenomas (TA), tubulovillous adenomas (TVA), or 
villous adenomas (VA). Serrated lesions included sessile serrated polyps/adenomas (SSP), 
hyperplastic polyps (HP), and traditional serrated adenomas. Advanced synchronous 
conventional adenomas were defined as lesions ≥ 10 mm in size, or lesions with high grade 
dysplasia, cancer, or villous elements. Advanced synchronous serrated lesions included SSP ≥ 10 
mm and SSP with cytological dysplasia. HP ≥ 10 mm in size were recorded separately. Serrated 
polyposis syndrome (SPS) was defined based on World Health Organization criteria: 1) ≥ 5 
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serrated class polyps (SSP or HP) proximal to the sigmoid colon with 2 or more ≥ 10 mm; 2) any 
number of serrated class polyps proximal to the sigmoid colon in a patient with a first-degree 
relative with SPS; 3) ≥ 20 serrated class polyps distributed throughout the colon.12 
 
Statistical analysis was performed using SPSS version 23 (IBM, New York, NY). Means and 
standard deviations were calculated for continuous variables. Means between groups were 
compared using either the Student’s t-test for normal distribution or the Wilcoxon rank sum test. 
 
Results 
There were 1029 consecutive patients with sessile or flat lesions ≥ 20 mm in diameter that were 
identified in the database. 296 patients were excluded because they only had 1 colonoscopy 
performed by DKR. Patients had only one colonoscopy if they did not return to our center for 
follow-up (n = 239), if they were referred for surgical resection because the index lesion had 
endoscopic features of cancer (these lesions were biopsied and referred to surgery, n = 24), or if 
they were considered endoscopically unresectable (n = 33). Three patients were excluded for 
known familial adenomatous polyposis at the time of referral.  Two were excluded because the 
index LLST was an inflammatory polyp. 728 patients with an LLST resected and who underwent 
two colonoscopies by DKR were included in this study. 
 
Of the 728 patients, the mean age was 65.8 ± 10.5 years (range 24-90 y) and 349 (47.9%) were 
female. The mean interval between the two colonoscopies was 144 days (range 12-365 days).  
The largest LLST for which the patient was referred for endoscopic resection was considered the 
index lesion, and all additional lesions were considered synchronous. The index lesion was 
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determined by the referring doctor’s colonoscopy report and in most cases was tattooed by the 
referring physician. The 728 index LLSTs are described in Table 1 by histology and location. 
The size of the LLST ranged from 20-29 mm (n=292), 30-39 mm (n=255), 40-49 mm (n=87), 
50-59 mm (n=67), and greater than 60 mm (n=27). 
 
A total of 4578 synchronous lesions were resected, which are described in Table 2 by histology, 
size, and location. 584 patients (80.2%) had at least one synchronous conventional adenoma, 132 
(18.1%) had at least one synchronous conventional adenoma ≥ 20 mm in size, 294 (40.4%) had 
at least one synchronous advanced conventional adenoma, and 6 patients had a synchronous 
lesion with cancer. 2174 (47.5%) of the synchronous polyps were located in the same colon 
segment or in an adjacent segment to the LLST, and 2404 (52.5%) of the synchronous polyps 
were located more than one segment away from the LLST. 
 
In 594 patients with only 1 LLST, there were 3266 synchronous lesions resected, including 2323 
synchronous conventional adenomas, 336 synchronous advanced conventional adenomas, 125 
synchronous SSP, and 38 synchronous HP ≥ 10 mm. 459 (77.3%) had at least one synchronous 
conventional adenoma, 162 (27.3%) had at least one synchronous advanced conventional 
adenoma, and 6 patients had a synchronous lesion with cancer. 
 
Table 3 compares the number of synchronous lesions per patient between different groups of 
patients. Those patients for whom their colonoscopy and pathology report from the referring 
institution were in our database had more synchronous adenomas (5.5 vs 3.7; p<0.001) and more 
synchronous serrated class lesions (2.7 vs 0.9; p<0.001). Patients with an adenomatous index 
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LLST compared to those with a serrated index LLST had more synchronous conventional 
adenomas (4.8 vs 2.9, p=0.001) and fewer synchronous serrated class lesions (1.4 vs 4.5, 
p<0.001). Patients with more than 1 LLST had more synchronous lesions (9.9 vs 5.5, p<0.001). 
Male patients had more synchronous adenomas (5.3 vs 3.6, p<0.001). 
 
There were 37 patients who had newly diagnosed serrated polyposis syndrome, and they had 
significantly more serrated lesions compared with the other patients (10.0 vs 1.4, p<0.001). The 
criteria for SPS in the 37 patients included 33 with WHO criteria 1, one with WHO criteria 2, 
and three with WHO criteria 3. Of the 97 patients with a serrated index LLST, 28 (28.9%) met 
criteria for SPS. 
 
There were 13 patients (1.8%) identified with cancer in this population, including 7 with cancer 
in the resected index lesion and 6 (0.8%) with cancer in a synchronous lesion. In these patients, 
the size of the synchronous cancers averaged 14.7 mm (range 10-20 mm), and the size of the 
index LLST cancers averaged 33 mm (range 20-65 mm). All of the 6 synchronous cancers 
occurred in referred patients and were depressed lesions with residual conventional adenoma 
(Figure 1). 
 
Discussion 
In this report we describe the prevalence of synchronous lesions in 728 primarily referred 
patients with large flat or sessile colorectal lateral spreading tumors who underwent colonoscopic 
clearance over two colonoscopies by a single expert endoscopist. The prevalence of synchronous 
conventional adenomas and synchronous serrated class lesions was very high. Our study 
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indicates that patients with large sessile or flat lateral spreading tumors ≥ 20 mm in size demand 
detailed clearance of the colon for synchronous lesions. Patient should also have lesions counted 
to see if they meet the criteria for serrated polyposis, as 28.9% of patients with an index serrated 
lesion greater than 20 mm in size met the criteria for serrated polyposis. 
 
Prior studies demonstrated a high rate of advanced synchronous conventional adenomas (27%-
44%) in patients with serrated class polyps ≥ 10 mm.5-9,11 We also found a high rate of 
synchronous conventional adenomas in patients with large serrated polyps ≥ 20 mm, but we also 
demonstrated a high risk of synchronous serrated class lesions in this population.  Only two prior 
studies characterized synchronous lesions in patients with conventional adenomas ≥ 20 mm.3,4 
The larger study4 included 582 patients who underwent EMR of large flat colon polyps ≥ 20 mm 
with a complete colonoscopy. Relevant findings of that study included 67% of patients with 
synchronous polyps, 52% with synchronous adenomas with low grade dysplasia, 8% with 
synchronous adenomas with high grade dysplasia, and 17% with synchronous serrated class 
lesions. Our findings demonstrate an even higher prevalence of synchronous lesions in a 
primarily referred patient population. The demonstration of patients with synchronous cancers is 
also concerning and emphasizes the need for detailed clearing of the colon. In this report 6 of 
658 referred patients (0.9%) had a synchronous cancer in the colon that had escaped detection by 
the referring physician. In this study all of the synchronous cancers were flat depressions lesions, 
and this shape likely contributed to their escaping detection by the referring physician. 
 
We found that synchronous lesions were common both within the same segment as the LLST 
and in segments distant from the LLST. Thus, our data indicate the need to clear the entire colon 
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carefully in patients with LLSTs. Interval cancers (post colonoscopy cancers) have been 
estimated to result largely from missed lesions but a minority of interval cancers are usually 
attributed to incomplete polypectomy.13,14 The basis for implicating incomplete polypectomy in 
specific interval cancer cases is usually that the interval cancer arose in the same colonic 
segment where a polypectomy had been performed.13,14 The high prevalence of synchronous pre-
cancerous lesions in the same segment as the LLST suggests that in some cases interval cancers 
attributed to incomplete polypectomy were rather the result of missed synchronous lesions. 
 
Our data suggest that large numbers of synchronous lesions in patients referred to our center 
were missed by referring colonoscopists. However, we speculate that the referring endoscopist 
sometimes stops looking for additional lesions once a need for referral is determined. This may 
be especially true for lesions in the same segment as the LLST, since the referring physician 
might reasonably consider that if we could not resect the LLST endoscopically at our center, that 
subsequent segmental surgical resection to remove the LLST would also remove synchronous 
lesions in the same segment. Alternatively, the bowel preparation at the initial examination 
performed by the referring physician might have interfered with detection of lesions, as poor 
bowel preparation is known to be followed by detection of a high yield of pre-cancerous polyps 
at follow-up examinations.15 The precise reasons for the referring doctor leaving large numbers 
of synchronous lesions in the colon remain uncertain, so that we are unwilling to suggest that 
most lesions were missed by the referring colonoscopy. Rather, our data from the referring 
physician’s records plus our finding establishes a remarkably high prevalence of synchronous 
neoplasia in patients with large LLSTs that demands careful and detailed complete colonoscopic 
clearance of the colon in patients with LLSTs. 
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Strengths of our study include its large size. This is the single largest cohort of lesions ≥ 20 mm 
in size resected by a single endoscopist or at a single center in the medical literature, and the 
largest study to address LLST and their synchronous polyps that includes the results of both a 
baseline and a second follow-up examination within one year. A second strength of the study is 
that the endoscopist has a proven high detection rate for both conventional adenomas16,17 and 
serrated lesions16,18. This high detection rate should maximize the prevalence of synchronous 
lesions determined in the study. In addition, many patients in this report had other polyps 
resected by the referring endoscopist prior to referral of the index LLST to our center and the 
outside reports were available in only 49.8% (328 of 658) of the referred patients. Thus, the very 
high prevalence of synchronous lesions reported here underestimates the true prevalence of 
synchronous lesions in this population. Third, our study reports rates of synchronous lesions in 
patients with both large conventional adenomatous LLSTs and large serrated LLSTs. We have 
demonstrated that patients with large conventional adenomatous LLSTs have more synchronous 
conventional adenomas than serrated class lesions, and conversely patients with large serrated 
LLSTs have more synchronous serrated class lesions than conventional adenomas. Finally, the 
database used to determine rates of synchronous lesions in this study was created prospectively, 
though the current analysis was performed retrospectively. 
 
The main limitation in this study is the likelihood of referral bias. Thus, the average size of the 
index LLST likely exceeds that of LLSTs that would be encountered by colonoscopists during 
routine colonoscopy. Further, in some instances, the referring physician may have been aware 
that multiple other lesions were present in addition to the index lesion, and referred the patient 
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partly because of the multiplicity of lesions rather than the difficulty of resecting the index lesion 
alone. However, we also found a high rate of synchronous lesions in the smaller number of study 
subjects (n=70; Table 3) whose index lesion was detected by the study endoscopist. Thus, 
despite the potential for referral bias, our results emphasize the need for colonoscopists to 
understand that patients with LLSTs can have extensive synchronous disease and require detailed 
clearing of the entire colon. 
 
This report has potential implications for post polypectomy surveillance guidelines. The US 
Multi-Society Task Force recommended that patients with large sessile and flat lesions removed 
in piecemeal fashion should have a follow-up endoscopy to examine the site in 3 to 6 months.1,19 
Our own practice is to perform two follow-ups, one in the first 3 to 6 months, and the second 
approximately one year later.4,20 The Australian experience on follow-up of large lesions 
removed by EMR, which is the largest consortium experience of EMR of large colorectal lesions 
reported, utilizes a very similar protocol.21 Our data indicate that in addition to inspection of the 
index lesion resection site for recurrence, patients with LLST should also have a detailed 
inspection of the entire colon during these follow-up examinations. Our data also confirm a 
general tendency towards a high prevalence of synchronous lesions in patients with larger 
colorectal polyps.4 Compared to the US recommendations for post polypectomy surveillance, 
guidelines in the UK have a broader range of surveillance interval stratification between the 
highest and lowest risk patients.22 In the UK guidelines, patients with 3 or more adenomas, of 
which one is ≥ 10 mm in size, should have a follow-up examination in one year. US guidelines 
recommend that patients who have >10 adenomas should undergo colonoscopy in less than 3 
years, with no reference to lesion size. The findings of a very high rate of synchronous lesions in 
13 
 
our study would tend to support a movement toward greater surveillance interval stratification in 
US recommendations at the high risk end of the risk spectrum, including shorter term follow-up 
and careful clearing for patients with multiple lesions that includes a large lesion. 
 
In conclusion, there is a very high prevalence of synchronous lesions, including advanced 
synchronous lesions, in patients with large lateral spreading tumors. Patients with such lesions 
need detailed clearing of the remainder of the colon. Patients referred for endoscopic resection of 
serrated lesions ≥ 20 mm have a high prevalence of serrated polyposis. 
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Table 1. Location and histology of index large lateral spreading tumors in 728 patients 
 Tubular 
adenoma 
Tubulovillous 
adenoma 
Villous adenoma Sessile serrated 
polyps 
Hyperplastic 
polyps 
Cancer 
Rectum 19 49 7 1 0 2 
Sigmoid 15 17 3 2 2 2 
Descending 12 7 1 4 3 1 
Splenic flexure 3 6 1 0 0 0 
Transverse 69 24 0 10 2 1 
Hepatic flexure 9 16 1 9 1 1 
Ascending 91 92 5 42 4 0 
Ileocecal valve 16 25 1 3 1 0 
Cecum 58 75 2 11 2 0 
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Table 2. Location, histology, and size of 4578 resected synchronous lesions 
 Tubular 
adenoma 
Tubulovillous 
adenoma 
Villous adenoma Sessile serrated 
polyps 
Hyperplastic 
polyps 
Cancer 
<1 cm ≥1 cm <1 cm ≥1 cm <1 cm ≥1 cm < 1 cm ≥ 1 cm < 1 cm ≥ 1 cm  
Rectum 80 12 5 4 0 1 4 1 206 5 1 
Sigmoid 325 44 18 21 0 3 29 7 334 16 2 
Descending 256 38 3 7 0 2 10 3 65 9 1 
Splenic flexure 19 3 0 0 0 0 0 0 3 0 0 
Transverse 744 86 19 12 2 0 35 22 135 17 1 
Hepatic flexure 86 17 2 3 0 0 7 7 31 6 0 
Ascending 768 143 49 33 2 5 50 39 109 26 0 
Ileocecal valve 16 10 1 2 0 1 0 0 7 0 0 
Cecum 349 53 22 14 0 0 10 13 78 8 1 
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Table 3. Number of synchronous lesions per patient compared between different patient groups. 
 
  Synchronous 
lesions per 
patient 
p Synchronous 
adenomas per 
patient 
p Synchronous 
serrated lesions 
per patient 
p 
Index lesion Adenoma (n=624) 6.2 0.06 4.8 0.001 1.4 <0.001 
 Serrated lesion (n=97) 7.4  2.9  4.5  
Index lesion, excluding SPS Adenoma (n=616) 6.0 0.16 4.8 <0.001 1.2 <0.001 
 Serrated lesion (n=69) 5.0  2.4  2.6  
# LLST 1 (n=596) 5.5 <0.001 3.9 <0.001 1.6 0.001 
 >1 (n=132) 9.9  7.3  2.6  
Gender Male (n=380) 7.1 <0.001 5.3 <0.001 1.8 0.68 
 Female (n=348) 5.5  3.6  1.9  
Serrated polyposis syndrome Yes (n=37) 14.7 <0.001 4.6 0.92 10.1 <0.001 
 No (n=691) 5.9  4.5  1.4  
Referral Referred (n=658) 6.5 0.02 4.6 0.10 1.9 0.07 
 Not referred (n=70) 4.7  3.5  1.2  
Outside report of 660 referred Available (n=328) 8.2 <0.001 5.5 <0.001 2.7 <0.001 
 Not available (n=330) 4.8  3.7  1.1  
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Figure 1. Four of the six synchronous cancers identified during the study. All 6 were relatively flat lesions with depressed centers 
 
